Drugs that contain Gemcitabine Hydrochloride
1. List of Infugem drug patents
INFUGEM's oppositions filed in EPO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9241948 | SUN PHARM | Ready to be infused gemcetabine solution |
Jul, 2033
(10 years from now) | |
Market Authorisation Date: 16 July, 2018
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
INFUGEM family patents
3
China
2
India
1
Portugal
1
Slovenia
1
Korea, Republic of
1
Poland
1
United States
1
Australia
1
Canada
1
Russia
1
Mexico
1
South Africa
1
Spain
1
Japan
1
Brazil
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic